about
Redox activation of metal-based prodrugs as a strategy for drug deliveryCytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivativesGold(I) complexes of 9-deazahypoxanthine as selective antitumor and anti-inflammatory agentsRevealing Three Stages of DNA-Cisplatin Reaction by a Solid-State NanoporeIn situ imaging of metals in cells and tissuesDownregulation of oncogenic RAS and c-Myc expression in MOLT-4 leukaemia cells by a salicylaldehyde semicarbazone copper(II) complexDisturbance of DNA conformation by the binding of testosterone-based platinum drugs via groove-face and intercalative interactions: a molecular dynamics simulation study.Synthesis, CP-MAS NMR Characterization, and Antibacterial Activities of Glycine and Histidine Complexes of Cd(SeCN) 2 and Hg(SeCN) 2.Antitumor activity of new enantiopure pybox-ruthenium complexes.Targeting the endoplasmic reticulum with a membrane-interactive luminescent ruthenium(ii) polypyridyl complex†Electronic supplementary information (ESI) available: Experimental details, characterization of 2 and Fig. S1-S6. See DOI: 10.1039/c3sc5172Water-soluble oxoglaucine-Y(III), Dy(III) complexes: in vitro and in vivo anticancer activities by triggering DNA damage, leading to S phase arrest and apoptosis.Water soluble, cyclometalated Pt(ii)-Ln(iii) conjugates towards novel bimodal imaging agents.DNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium(ii) terpyridine complexes.Heteroleptic mononuclear compounds of ruthenium(ii): synthesis, structural analyses, in vitro antitumor activity and in vivo toxicity on zebrafish embryos.Dibutyltin(IV) complexes containing arylazobenzoate ligands: chemistry, in vitro cytotoxic effects on human tumor cell lines and mode of interaction with some enzymes.Oxoaporphine Metal Complexes (CoII, NiII, ZnII) with High Antitumor Activity by Inducing Mitochondria-Mediated Apoptosis and S-phase Arrest in HepG2.Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK SignalingTitanium salan complexes displays strong antitumor properties in vitro and in vivo in miceExploring the cellular accumulation of metal complexes.Enhanced Cytotoxicity through Conjugation of a "Clickable" Luminescent Re(I) Complex to a Cell-Penetrating Lipopeptide2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds.Osmium(VI) complexes as a new class of potential anti-cancer agents.Novel C,N-chelate rhodium(III) and iridium(III) antitumor complexes incorporating a lipophilic steroidal conjugate and their interaction with DNA.Structure-based DNA-targeting strategies with small molecule ligands for drug discovery.Gold(III)-dithiocarbamato peptidomimetics in the forefront of the targeted anticancer therapy: preclinical studies against human breast neoplasia.Ultrafast photo-induced ligand solvolysis of cis-[Ru(bipyridine)2(nicotinamide)2](2+): experimental and theoretical insight into its photoactivation mechanism.Metal-ion-dependent folding of a uranyl-specific DNAzyme: insight into function from fluorescence resonance energy transfer studies.Anticancer Gold(III) Porphyrins Target Mitochondrial Chaperone Hsp60.Anticancer Activity of Self-Assembled Molecular Rectangles via Arene-Ruthenium Acceptors and a New Unsymmetrical Amide LigandTargeting of DNA molecules, BSA/c-Met tyrosine kinase receptors and anti-proliferative activity of bis(terpyridine)copper(ii) complexes.Luminescent di- and polynuclear organometallic gold(I)-metal (Au2, {Au2Ag}n and {Au2Cu}n) compounds containing bidentate phosphanes as active antimicrobial agents.Titanates and Titanate-Metal Compounds in Biological ContextsKinetics and thermodynamics of irreversible inhibition of matrix metalloproteinase 2 by a Co(III) Schiff base complexPolymeric Micelle-Mediated Delivery of DNA-Targeting Organometallic Complexes for Resistant Ovarian Cancer Treatment.Tuning cobalt(III) Schiff base complexes as activated protein inhibitors.Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics folloLight-Sensitive Ruthenium Complex-Loaded Cross-linked Polymeric Nanoassemblies for the Treatment of CancerAxial ligand exchange of N-heterocyclic cobalt(III) Schiff base complexes: molecular structure and NMR solution dynamics.Photodynamic killing of cancer cells by a Platinum(II) complex with cyclometallating ligand.Cobalt derivatives as promising therapeutic agents
P2860
Q27025736-A08F78D2-3D36-46F6-8353-42C79CCED524Q27702884-7AD65D90-DFD6-4688-843D-A3B8E604A4B7Q28543791-A0F7AF54-704C-4C86-9F2D-689486C8A7BAQ28647465-EBC59D4D-D22A-4E01-B0F7-8E1B0854333EQ28662002-AD2E3C42-F2AD-4353-974A-DE782B0A31A8Q28821489-181C482B-FA56-4BA6-91C7-FD41CD912D12Q30538107-F603C555-BC5B-4490-9992-8153DA791DDCQ30607777-144C2230-FE14-4AA2-AA99-F8CE583AD3A8Q30660221-E5D6779C-6F57-49EA-B68E-FEF516AFE887Q30884078-9DE92C76-75CF-4D33-9593-D6A8608846E3Q30959736-F6A03392-C869-47C1-82B8-CCD7FDC3EC3CQ30978325-3B8D15F9-ABDB-4731-B79C-2A0228CDD350Q31043552-7B7F0894-315B-460B-AF7D-D0F0360EE1BAQ31143548-D30AB8F4-D28B-4B1F-B2A3-28B88410D11EQ33518618-2C381C04-E8B2-4FB4-977D-5534ABB68351Q33594393-7EA1160D-3E16-434C-8FBA-BD2F985D9182Q33754805-3BF429F5-FFE8-4A9D-AAC0-B954B5FE18B7Q33857149-CA6C8140-E8B8-4ED6-89FB-63EDACEF6B41Q33866011-43B132CD-0CE8-42E5-B831-D209DA7CB46BQ33889086-D22E8ED6-D7C3-40EB-902D-7392E85DB6F1Q34089015-AE8B3ECD-25EC-48A9-9BA5-8CFB4745F854Q34157363-55A8BF10-0699-4204-A714-96C07310AD73Q34415646-DC408B48-9FA7-48D7-BBFD-94F0BC157D92Q34697484-81848B5D-962F-47EC-9939-54DEB13C7672Q35083349-5097A7D2-89FB-4A2E-AE00-E2A7EF73064BQ35212794-7DF47EA6-66E7-4FB5-8C8C-31F9F916FF87Q35851631-DB72E9E0-CE90-4502-BE90-0F98F0FDD290Q35867952-549B32F8-3412-4D14-8F2B-73264C230EC2Q35983960-C54B8822-CB50-42CE-8524-B07E1EF9E500Q35985323-CC8D5642-DA07-4A58-9D2D-B368F06CF4E1Q36021556-C16D9FF0-7636-49CA-95A8-9DAE4B62C0C1Q36104993-1060240C-5FD7-433B-8C8E-B7D0E30F09AFQ36160999-EEED9449-CFC2-4C28-A599-DF14D69B6A26Q36253687-8E3E074A-7C63-4D66-A5F9-30380A0FF74BQ36263648-EC6D0DB8-CFFD-4B50-83E7-6B9C7B564613Q36476481-B7BFD44B-5B46-4EF1-9C3D-EC3EF844FECCQ36539791-B76A425E-B7BA-48CB-8A3C-AE74B677837BQ36560196-93A1A723-FA39-4C48-9CBC-D4F4E5CD908CQ36651264-7EB31A4F-2ECB-4DAD-93FB-AB10CA8F63ACQ36756033-F27B49CB-B994-471C-8672-EA26B68AF7E8
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New trends for metal complexes with anticancer activity
@en
New trends for metal complexes with anticancer activity.
@nl
type
label
New trends for metal complexes with anticancer activity
@en
New trends for metal complexes with anticancer activity.
@nl
prefLabel
New trends for metal complexes with anticancer activity
@en
New trends for metal complexes with anticancer activity.
@nl
P2860
P1476
New trends for metal complexes with anticancer activity
@en
P2093
Peter J Sadler
P2860
P304
P356
10.1016/J.CBPA.2007.11.013
P577
2008-01-25T00:00:00Z